曼尼托巴省不同透析方式的治疗成本
该研究从加拿大单一支付方医疗系统视角构建成本最小化模型,估算曼尼托巴省七橡树综合医院肾脏项目的透析成本。结果显示,中心血透年维持费用最高,为64214加元;腹膜透析最低,为38658加元;居家血透介于两者之间。从中心血透转换至居家透析,需分别经过9.7、12.6、3.2个月的短期时间后实现成本中性。
要点
- 中心血透年维持费用最高,居家血透与腹膜透析更低
- 腹膜透析年维持费用最低,为38658加元
- 转换至居家透析后的成本中性时间阈值为3.2至12.6个月
核心结论
- 居家透析方式维持成本更低,考虑增量培训费用后,超过短期时间即更具成本效率。
研究设计与样本
- 研究构建成本最小化模型,从加拿大单一支付方医疗系统视角纳入透析相关全部成本。
- 成本包含基于活动的每患者直接劳动力需求分解,其他成本取自七橡树综合医院肾脏项目运营报表,均以加元报告。
主要发现
- 年维持费用:中心血透64214加元,NxStage System One居家血透43816加元,传统透析机居家血透39236加元,腹膜透析38658加元。
- 培训费用:中心血透0加元,NxStage System One居家血透16143加元,传统透析机居家血透24379加元,腹膜透析7157加元。
- 成本中性阈值:中心血透转NxStage居家血透需9.7个月,转传统透析机居家血透需12.6个月,转腹膜透析需3.2个月。
临床怎么用
- 在规划透析方式时,可参考本研究的成本数据比较不同方式的维持与培训费用。
- 从中心血透转换至居家透析时,可依据成本中性时间阈值评估经济性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The prevalence of ESKD is increasing worldwide. Treating ESKD is disproportionately costly in comparison with its prevalence, mostly due to the direct cost of dialysis therapy. Here, we aim to provide a contemporary cost description of dialysis modalities, including facility-based hemodialysis, peritoneal dialysis, and home hemodialysis, provided with conventional dialysis machines and the NxStage System One. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We constructed a cost-minimization model from the perspective of the Canadian single-payer health care system including all costs related to dialysis care. The labor component of costs consisted of a breakdown of activity-based per patient direct labor requirements. Other costs were taken from statements of operations for the kidney program at Seven Oaks General Hospital (Winnipeg, Canada). All costs are reported in Canadian dollars. RESULTS: Annual maintenance expenses were estimated as $64,214 for in-center facility hemodialysis, $43,816 for home hemodialysis with the NxStage System One, $39,236 for home hemodialysis with conventional dialysis machines, and $38,658 for peritoneal dialysis. Training costs for in-center facility hemodialysis, home hemodialysis with the NxStage System One, home hemodialysis with conventional dialysis machines, and peritoneal dialysis are estimated as $0, $16,143, $24,379, and $7157, respectively. The threshold point to achieve cost neutrality was determined to be 9.7 months from in-center hemodialysis to home hemodialysis with the NxStage System One, 12.6 months from in-center hemodialysis to home hemodialysis with conventional dialysis machines, and 3.2 months from in-center hemodialysis to peritoneal dialysis. CONCLUSIONS: Home modalities have lower maintenance costs, and beyond a short time horizon, they are most cost efficient when considering their incremental training expenses. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2018_07_18_CJASNPodcast_18_8_F.mp3.
引用
- Beaudry A, Ferguson TW, Rigatto C, et al. Cost of Dialysis Therapy by Modality in Manitoba. Clin J Am Soc Nephrol. 2018. PMID: 30021819. doi:10.2215/CJN.10180917
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。